Newsroom | 26382 results

CHANTILLY, Va.--(BUSINESS WIRE)--Amentum (NYSE: AMTM), a global leader in advanced engineering and innovative technology solutions, announced the award of a significant new contract from Atomic Energy of Canada Limited (AECL) to provide operations and management solutions for Canadian Nuclear Laboratories (CNL). Under this contract, Amentum will help advance nuclear science, technology, and innovation across Canada. “This contract award reflects our deep expertise in nuclear operations and envi...

ROCKVILLE, Md.--(BUSINESS WIRE)--The Maryland Tech Council, the largest technology and life sciences trade association in the state, is pleased to announce that Dr. Marty Makary, Commissioner of the Food and Drug Administration, will participate in a fireside chat at the 2025 Bio Innovation Conference on September 4, 2025 at the Bethesda North Marriott Hotel and Conference Center in Rockville, Maryland. Dr. Makary was confirmed on March 25, 2025 by a bipartisan vote of the U.S. Senate as the 27...

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a leader in generating real-world evidence (RWE) from high-quality healthcare data today announced a partnership with Kythera Labs, a leading healthcare data and technology company, adding to the growing number of datasets and use cases for the Atropos Evidence™ Network including oncology. This is the first step in a multiyear agreement between the two companies committed to turning data and knowledge of molecular biology in health and disease...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine. This multi-year collaboration aims to harness AI for rapid discovery and innovation in Alzheimer's disease research. The collaboration leverages Tempus’ AI-powered data analytics platform, Lens, to analyze and...

DARMSTADT, Germany--(BUSINESS WIRE)--Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an investigational, oral, novel TLR7/8 inhibitor in systemic lupus erythematosus (SLE). Although it did not meet the primary endpoint of dose-response relationship, when compared to placebo, enpatoran demonstrated improvements...

ALAMEDA, Calif.--(BUSINESS WIRE)--Infinimmune Launches GLIMPSE-1 AI Model Trained Exclusively on Human Antibody Sequences for Advanced Therapeutic Engineering...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025 conference in Bruges, Belgium. These new additions are designed to boost laboratory efficiency and deliver superior results. Exhibition attendees will be able to see how these products can streamline operations and enhance analytical outcomes. The Agilent Infinit...

MARTIGNY, Switzerland & LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a privately-owned Swiss biopharmaceutical company committed to establishing tomorrow’s standard of care to cure cancer and infectious diseases and Alkyon Therapeutics, Inc., a biotechnology company pioneering precision-targeted therapies, today announced the signing of a co-research agreement to evaluate the feasibility of developing targeted radioligand therapies (RLTs) using Debiopharm...

BOSTON--(BUSINESS WIRE)--Sensible Biotechnologies are accelerating the development of their cell-based platform for next-generation mRNA medicines with NVIDIA AI....

PARIS--(BUSINESS WIRE)--SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today announced the signature with SATT Conectus of an exclusive collaboration and worldwide license agreement for potent monoclonal antibodies targeting the BK virus. These monoclonal antibodies were developed through the project HuMAB...